Argenx
ARGX
#534
Rank
$38.14 B
Marketcap
$623.82
Share price
-0.35%
Change (1 day)
84.07%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total debt

Total debt on the balance sheet as of June 2024 : $33.96 Million USD

According to Argenx 's latest financial reports the company's total debt is $33.96 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Argenx - Total debt on balance sheet (from 2017 to 2020)

Total debt by year

Year Total debt Change
2022-12-31$12.42 M8.38%
2021-12-31$11.46 M-3.48%
2020-12-31$11.87 M44.87%
2019-12-31$8.19 M
2018-12-31N/A
2017-12-31N/A
2013-12-31N/A-100%
2012-12-31$2.95 M3.93%
2011-12-31$2.84 M